Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€20.40

€20.40

-5.560%
-1.2
-5.560%
€38.34
 
29.01.26 / Frankfurt WKN: A2PEAB / Symbol: CLDX / Name: Celldex / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Celldex

sharewise wants to provide you with the best news and tools for Celldex, so we directly link to the best financial data sources.

News

Celldex Therapeutics SVPs Engage In Heavy Transactions: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png?w=1401&h=1251
Celldex Therapeutics SVPs Engage In Heavy Transactions

On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President & General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.